By using our website, you agree to our use of cookies. find out more.
-
Products
Pharmacology
Type
- News
- Custom services
- Ordering
- About Us
- Technical support
- Resources
-
Products
Pharmacology
Type
- News
- Custom services
- Ordering
- About Us
- Technical support
- Resources
The amino acid alphabet was adaptively shaped by biophysical constraints of foldability
Published on April 3rd 2023
Modern proteins rely on an almost universal repertoire of 20 canonical amino acids which can be divided into 'early' and 'late' groups, based on when they were added to the amino acid alphabet. However, many nonproteinogenic amino acids were also prebiotically available but not incorporated. In a study investigating what drove this selectivity, researchers made peptides out of sets of amino acids and compared their solubility and how readily they arranged themselves into protein-like structures. Starting from a core of seven early amino acids, Hlouchová and coworkers added sets of other amino acids, made peptide libraries from each, and compared them with peptides made from 19 of the canonical amino acids. Two of the libraries included noncanonical but prebiotically available amino acids and one included amino acids with linear side chains such as norvaline and norleucine.
The canonical library formed more secondary structures like α helices and β sheets than either libraries made using only early amino acids, or libraries that contained one or more noncanonical amino acids. The results suggest that foldability was a critical factor in the selection of the canonical alphabet, with unbranched aliphatic amino acids being purged from the proteinogenic alphabet - despite their high prebiotic abundance - because they generate peptides that are oversolubilised and have low packing efficiency. The early canonical alphabet was most likely selected for supporting peptide folding, and was better adapted for creating proteins that bind cofactors, recognise RNA, and perform enzymatic catalysis.
Learn more
Contact Information
To place an order, or for customer services, order processing or technical support please contact us on:
UK, Europe and RoW
Tel: (+44) 01392 422205
Fax: (+44) 01392 279510
info@iscabiochemicals.com
USA and Canada
Tel: 610-994-1134
Toll Free: 855-FOCUS21 (855-362-8721)
Fax: 610-465-9100
France
CliniSciences
Tel : +33 9 77 40 09 09
Fax : +33 9 77 40 10 11
Orders and customer support : info@clinisciences.com
Germany, Switzerland, Austria
BIOZOL Diagnostics
Tel: +49 (089) 3799 666-6
Fax: +49 (089) 3799 666-99
Orders, Technical and Customer support: info@biozol.de
Italy
Labospace
Tel: +39 02 35980841
Fax +39 02 359808004
Orders: info@labospace.com
Spain and Portugal
Abyntek Biopharma
Tel: +34 94 404 80 80
Fax: +34 94 404 80 81
Orders: info@abyntek.com
BIOHUB INTERNATIONAL
上海起发实验试剂有限公司
Tel: +86-15921799099
Tel: +86-021-50724187
Fax: +86-021-50724961
Orders: sale3@78bio.com
India
BTL Biotechno Labs Pvt Ltd
Tel: +91-8860924629
07291852429
Orders, Technical and Customer support: info@biotechnolabs.com
Japan
Namiki Shoji Co.
Tel:+81-050-5527-9850
Fax:+81-3-3352-2196
email: globalbusiness1@namiki-s.co.jp
Recent citations
A new publication from the University of Ljubljana uses MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2, the FRET substrate for the severe acute respiratory syndrome coronavirus main protease (SARS-CoV Mpro), to determine the inhibitory potential of plant polyphenols
Learn moreContact us
Isca Biochemicals
26 Hanover Road
Exeter
EX1 2TL
(+44) 01392 422205
info@iscabiochemicals.com